Bilha Schechter
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 5%
- HER2/EGFR in Cancer Research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 21
- Oncology 20
- HER2/EGFR in Cancer Research 5
- Co-authors
- Michael SelaRuth ArnonMeir WilchekIsraël SchechterYosef YardenSara LaviMichaël FeldmanZvia Agur
- Journals
- International Journal of Cancer (7 papers)European Journal of Biochemistry (5 papers)Proceedings of the National Academy of Sciences (4 papers)The Journal of Immunology (3 papers)Journal of drug targeting (2 papers)
- Partner nations
- IsraelUnited StatesSouth Africa
In The Last Decade
Bilha Schechter
70 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 112
- Radiology, Nuclear Medicine and Imaging 691
- Oncology 540
- Immunology 394
- Modeling and Simulation 75
- Molecular Biology 1.0k
Countries citing papers authored by Bilha Schechter
This map shows the geographic impact of Bilha Schechter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bilha Schechter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bilha Schechter more than expected).
Fields of papers citing papers by Bilha Schechter
This network shows the impact of papers produced by Bilha Schechter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bilha Schechter. The network helps show where Bilha Schechter may publish in the future.
Co-authors
The 25 scholars most cited alongside Bilha Schechter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 4 | |
| 2 | 2015 | 10 | |
| 3 | 2013 | 37 | |
| 4 | 2009 | 149 | |
| 5 | 2007 | 41 | |
| 6 | 2002 | 16 | |
| 7 | 2001 | 5 | |
| 8 | 1999 | 8 | |
| 9 | 1998 | 43 | |
| 10 | 1997 | 44 | |
| 11 | 1997 | 2 | |
| 12 | 1995 | 35 | |
| 13 | 1993 | 3 | |
| 14 | 1992 | 3 | |
| 15 | 1992 | 34 | |
| 16 | Zidovudine toxicity to murine bone marrow may be affected by the exact frequency of drug administration. | 1991 | 18 |
| 17 | 1990 | 81 | |
| 18 | 1989 | 22 | |
| 19 | 1988 | 69 | |
| 20 | 1987 | 20 |
About Bilha Schechter
Bilha Schechter is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Neuropsychology and Physiological Psychology, Immunology and Organic Chemistry, having authored 70 papers that have together received 2.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (21 papers), Glycosylation and Glycoproteins Research (9 papers), Biotin and Related Studies (7 papers), Biopolymer Synthesis and Applications (7 papers), Click Chemistry and Applications (7 papers), RNA Interference and Gene Delivery (6 papers), Ferrocene Chemistry and Applications (6 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (691 citations), Oncology (540 citations), Immunology (394 citations), Modeling and Simulation (75 citations) and Molecular Biology (1.0k citations). Bilha Schechter has collaborated with scholars based in Israel, United States and South Africa. Frequent co-authors include Michael Sela, Ruth Arnon, Meir Wilchek, Israël Schechter, Yosef Yarden, Sara Lavi, Michaël Feldman, Zvia Agur, Tsipi Ben-Kasus and Yosef Yarden. Their work appears in journals such as International Journal of Cancer, European Journal of Biochemistry, Proceedings of the National Academy of Sciences, The Journal of Immunology and Journal of drug targeting.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.